.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cerilliant
Argus Health
Colorcon
Fish and Richardson
US Army
Covington
Chinese Patent Office
Novartis
UBS

Generated: September 20, 2017

DrugPatentWatch Database Preview

BUTISOL SODIUM Drug Profile

« Back to Dashboard

Which patents cover Butisol Sodium, and when can generic versions of Butisol Sodium launch?

Butisol Sodium is a drug marketed by Meda Pharms and Mylan Speciality Lp and is included in two NDAs.

The generic ingredient in BUTISOL SODIUM is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.

Summary for Tradename: BUTISOL SODIUM

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list22
Clinical Trials: see list2,385
Patent Applications: see list1,705
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUTISOL SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms
BUTISOL SODIUM
butabarbital sodium
ELIXIR;ORAL085380-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
BUTISOL SODIUM
butabarbital sodium
TABLET;ORAL000793-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
BUTISOL SODIUM
butabarbital sodium
TABLET;ORAL000793-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
BUTISOL SODIUM
butabarbital sodium
TABLET;ORAL000793-004Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
BUTISOL SODIUM
butabarbital sodium
TABLET;ORAL000793-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Farmers Insurance
Chinese Patent Office
Queensland Health
Teva
Mallinckrodt
AstraZeneca
Deloitte
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot